JP2026503618A5 - - Google Patents
Info
- Publication number
- JP2026503618A5 JP2026503618A5 JP2025542419A JP2025542419A JP2026503618A5 JP 2026503618 A5 JP2026503618 A5 JP 2026503618A5 JP 2025542419 A JP2025542419 A JP 2025542419A JP 2025542419 A JP2025542419 A JP 2025542419A JP 2026503618 A5 JP2026503618 A5 JP 2026503618A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- compound according
- independently selected
- isopropyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363481202P | 2023-01-24 | 2023-01-24 | |
| US63/481,202 | 2023-01-24 | ||
| PCT/US2024/011943 WO2024158607A1 (en) | 2023-01-24 | 2024-01-18 | Substituted 1h-pyrazole-4-carboxamides as sarm1 inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2026503618A JP2026503618A (ja) | 2026-01-29 |
| JP2026503618A5 true JP2026503618A5 (https=) | 2026-02-24 |
Family
ID=89983825
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025542419A Pending JP2026503618A (ja) | 2023-01-24 | 2024-01-18 | Ｓａｒｍ１阻害剤としての置換された１ｈ－ピラゾール－４－カルボキサミド |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP4655295A1 (https=) |
| JP (1) | JP2026503618A (https=) |
| CN (1) | CN120826394A (https=) |
| AR (1) | AR131685A1 (https=) |
| TW (1) | TW202444700A (https=) |
| WO (1) | WO2024158607A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025243724A1 (ja) * | 2024-05-20 | 2025-11-27 | 国立研究開発法人国立精神・神経医療研究センター | 神経保護剤 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112839647B (zh) | 2018-06-07 | 2025-09-23 | 达萨玛治疗公司 | Sarm1抑制剂 |
| WO2021142006A1 (en) | 2020-01-07 | 2021-07-15 | Disarm Therapeutics, Inc. | Inhibitors of sarm1 |
-
2024
- 2024-01-18 WO PCT/US2024/011943 patent/WO2024158607A1/en not_active Ceased
- 2024-01-18 CN CN202480020068.8A patent/CN120826394A/zh active Pending
- 2024-01-18 EP EP24706329.0A patent/EP4655295A1/en active Pending
- 2024-01-18 JP JP2025542419A patent/JP2026503618A/ja active Pending
- 2024-01-24 TW TW113102816A patent/TW202444700A/zh unknown
- 2024-01-24 AR ARP240100169A patent/AR131685A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006501181A5 (https=) | ||
| JP2012523457A5 (https=) | ||
| RU2007116119A (ru) | Производные циклоспорина, замещенные 3-эфиром и 3-тиоэфиром, для лечения и профилактики инфекционного гепатита с | |
| RU2010126105A (ru) | Производные пиридина, замещенные гетероциклическим кольцом и фосфоноксиметильной группой, и содержащие их противогрибковые средства | |
| JP2024119812A5 (https=) | ||
| JP2022081661A5 (https=) | ||
| JP2006515858A5 (https=) | ||
| JP2013508279A5 (https=) | ||
| JP2003506354A5 (https=) | ||
| JP2004518723A5 (https=) | ||
| JP2005523922A5 (https=) | ||
| JP2009536660A5 (https=) | ||
| RU2005105592A (ru) | Макролидные соединения, обладающие противовоспалительной активностью | |
| CA2361364A1 (en) | Dalda analogs and their use | |
| JP2022548247A5 (https=) | ||
| RU2008119651A (ru) | Производные дикарбоновых кислот и их применение | |
| JP2005517677A5 (https=) | ||
| RU2394031C2 (ru) | Соли четвертичного аммония в качестве антагонистов м3 | |
| CA2471265A1 (en) | Pyrimidotriazines as phosphatase inhibitors | |
| JP2026503618A5 (https=) | ||
| JP2006516626A5 (https=) | ||
| JP2004525183A5 (https=) | ||
| JP2004525178A5 (https=) | ||
| KR940702491A (ko) | 옥사졸리돈 유도체 | |
| JP2004523478A5 (https=) |